Use of real world data to improve drug coverage decisions in China

Wen Wang; Jing Tan; Jing Wu; Shiyao Huang; Yunxiang Huang; Feng Xie; Xin Sun

doi:10.1136/bmj-2021-068911

Use of real world data to improve drug coverage decisions in China

BMJ. 2023 Jun 15:381:e068911. doi: 10.1136/bmj-2021-068911.

Authors

Wen Wang^{1

2

3}, Jing Tan^{1

2

3}, Jing Wu⁴, Shiyao Huang^{1

2

3}, Yunxiang Huang^{1

2

3}, Feng Xie⁵, Xin Sun^{1

2

3}

Affiliations

¹ Chinese Evidence-based Medicine Centre, and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
² NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, China.
³ Sichuan Center of Technology Innovation for Real World Data, Chengdu, China.
⁴ School of Pharmacology Science and Technology, Tianjin University, Tianjin, China.
⁵ Department of Clinical Epidemiology and Biostatistics, University of Macmaster, Hamilton, Canada.

Abstract

Wen Wang and colleagues discuss the rationale and propose a framework for using real world evidence to support coverage decisions in Chinese setting

MeSH terms

China
Decision Making*
Humans
Insurance, Health*